Radioactive 125I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients

doi:10.12998/wjcc.v9.i4.792

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6886)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

335

WORD

197

HTML

2479

Figures (1-2)

352

Tables (1-2)

333

Sum=3696

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

363

Download

952

Sum=1315

Publishing Process of This Article

Item

Count

Browse

519

Download

1356

Sum=1875

Feb 6, 2021 (publication date) through Nov 18, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Clin Cases. Feb 6, 2021; 9(4): 792-800
Published online Feb 6, 2021. doi: 10.12998/wjcc.v9.i4.792

Open in New Tab Full Size Figure Download Figure

Figure 1 Radioactive ¹²⁵I seeds implanted in pancreatic cancer patients with unexpected liver metastasis. A: Preoperative computed tomography (CT) showed the primary pancreatic cancer (arrow); B: Postoperative CT showed the radioactive ¹²⁵I seeds implanted in the pancreatic cancer.

Open in New Tab Full Size Figure Download Figure

Figure 2 Kaplan-Meier cumulative survival curves according to chemotherapy status. The median survival for 7 patients who received chemotherapy was 16.3 mo, which was significantly longer than that for 17 patients who did not (10 mo; P = 0.008).

Citation: Li CG, Zhou ZP, Jia YZ, Tan XL, Song YY. Radioactive ¹²⁵I seed implantation for pancreatic cancer with unexpected liver metastasis: A preliminary experience with 26 patients. World J Clin Cases 2021; 9(4): 792-800
URL: https://www.wjgnet.com/2307-8960/full/v9/i4/792.htm
DOI: https://dx.doi.org/10.12998/wjcc.v9.i4.792